Clinical Trials Using Allogeneic T-Lymphocytes BPX-501
Clinical trials are research studies that involve people. The clinical trials on this list are studying Allogeneic T-Lymphocytes BPX-501. All trials on the list are supported by NCI.
NCI’s basic information about clinical trials explains the types and phases of trials and how they are carried out. Clinical trials look at new ways to prevent, detect, or treat disease. You may want to think about taking part in a clinical trial. Talk to your doctor for help in deciding if one is right for you.
Rivogenlecleucel Donor Lymphocyte Immunotherapy in Treating Patients with Recurrent Blood Cancers after Stem Cell Transplant
This phase I trial studies the side effects and best dose of rivogenlecleucel, and how well it works, in treating patients with blood cancer that has come back (recurrent) after stem cell transplant. Donor T-cell therapy (rivogenlecleucel) may help control transplant-related infections after stem cell transplant.
Location: Fred Hutch / University of Washington Cancer Consortium, Seattle, Washington